SARS-COV-2&INFL A/B SELF-TEST
4.60€
- Brand: MY BENEFIT Srl
- Product Code: 985501980
- EAN: 6971792050129
- Availability: Out Of Stock
- Purchase 3 items for 4.51€ each
- Purchase 4 items for 4.42€ each
- Purchase 5 items for 4.32€ each
SARS-Cov-2&Flu A/B Combo
Description
In vitro diagnostic test for the qualitative detection of novel coronavirus antigens and influenza A and B antigens in nasal swabs from individuals with or without symptoms, using the rapid immunochromatographic method.
It is used for self-diagnosis.
This kit is intended for home use by a lay person in a non-laboratory setting (for example, in a person's residence or in some non-traditional locations such as offices, sporting events, airports, schools, etc.) The test results of this kit are for clinical reference only. A comprehensive disease analysis based on the patients' clinical manifestations and other laboratory findings is recommended.
The Novel Coronavirus Antigen Rapid Test Cassette (SARS-Cov-2) is a membrane chromatographic immunoassay that uses highly sensitive monoclonal antibodies to the Novel Coronavirus. The test device consists of the following three parts: i.e. sample pad, reagent pad and reaction membrane. The entire strip is secured within a plastic fixture. The reaction membrane contains colloidal gold conjugated with monoclonal antibodies against Novel coronavirus; the reaction membrane contains secondary antibodies to Novel coronavirus and polyclonal antibodies against mouse globulin, pre-immobilized on the membrane. When the sample is added to the sampling window, the dried conjugates in the reagent buffer dissolve and migrate with the sample. If Novel coronavirus is present in the sample, the complex formed between the anti Novel coronavirus conjugate and the virus will be captured by the specific anti Novel coronavirus monoclonal coated in the T area. Whether or not the sample contains the virus, the solution continues migrate to meet another reagent (an anti-mouse IgG antibody) which binds the remaining conjugates, thus producing a red line over the C region.
The Influenza A/B Rapid Test Cassette is a qualitative lateral flow immunoassay for the detection of Influenza A and Influenza B nucleoproteins in the nasal swab. In this test, antibodies specific to influenza A and influenza B nucleoproteins are coated separately in the test zones of the test device. During testing, the extracted sample reacts with influenza A and/or influenza B antibody that are coated on particles. The mixture migrates the membrane to react with influenza A and/or influenza B antibody on the membrane and generate one or two colored lines in the test regions. The presence of this colored line in one or both test regions indicates a positive result. To serve as a procedural control, a colored line will always appear in the control region if the test has been performed correctly.
How to use
Sample collection and preparation
1. Sample collection*
a) Wash or clean your hands for at least 20 seconds and make sure they are dry before starting the test.
b) It is applicable to the diagnosis of Novel coronavirus or Influenza A/B virus from nasal swab samples. For optimal assay performance, use freshly collected samples. Inadequate collection or improper specimen handling may give a false-negative result.
c) Unpack the swab. Caution: Do not touch the soft end of the swab and the swab must not come into contact with any other object, otherwise the result may be distorted.
d) Tilt your head back slightly. Insert the swab about 2 cm, at least with the entire soft tip of the swab, into the left nostril. Rotate gently
In vitro diagnostic test for the qualitative detection of novel coronavirus antigens and influenza A and B antigens in nasal swabs from individuals with or without symptoms, using the rapid immunochromatographic method.
It is used for self-diagnosis.
This kit is intended for home use by a lay person in a non-laboratory setting (for example, in a person's residence or in some non-traditional locations such as offices, sporting events, airports, schools, etc.) The test results of this kit are for clinical reference only. A comprehensive disease analysis based on the patients' clinical manifestations and other laboratory findings is recommended.
The Novel Coronavirus Antigen Rapid Test Cassette (SARS-Cov-2) is a membrane chromatographic immunoassay that uses highly sensitive monoclonal antibodies to the Novel Coronavirus. The test device consists of the following three parts: i.e. sample pad, reagent pad and reaction membrane. The entire strip is secured within a plastic fixture. The reaction membrane contains colloidal gold conjugated with monoclonal antibodies against Novel coronavirus; the reaction membrane contains secondary antibodies to Novel coronavirus and polyclonal antibodies against mouse globulin, pre-immobilized on the membrane. When the sample is added to the sampling window, the dried conjugates in the reagent buffer dissolve and migrate with the sample. If Novel coronavirus is present in the sample, the complex formed between the anti Novel coronavirus conjugate and the virus will be captured by the specific anti Novel coronavirus monoclonal coated in the T area. Whether or not the sample contains the virus, the solution continues migrate to meet another reagent (an anti-mouse IgG antibody) which binds the remaining conjugates, thus producing a red line over the C region.
The Influenza A/B Rapid Test Cassette is a qualitative lateral flow immunoassay for the detection of Influenza A and Influenza B nucleoproteins in the nasal swab. In this test, antibodies specific to influenza A and influenza B nucleoproteins are coated separately in the test zones of the test device. During testing, the extracted sample reacts with influenza A and/or influenza B antibody that are coated on particles. The mixture migrates the membrane to react with influenza A and/or influenza B antibody on the membrane and generate one or two colored lines in the test regions. The presence of this colored line in one or both test regions indicates a positive result. To serve as a procedural control, a colored line will always appear in the control region if the test has been performed correctly.
How to use
Sample collection and preparation
1. Sample collection*
a) Wash or clean your hands for at least 20 seconds and make sure they are dry before starting the test.
b) It is applicable to the diagnosis of Novel coronavirus or Influenza A/B virus from nasal swab samples. For optimal assay performance, use freshly collected samples. Inadequate collection or improper specimen handling may give a false-negative result.
c) Unpack the swab. Caution: Do not touch the soft end of the swab and the swab must not come into contact with any other object, otherwise the result may be distorted.
d) Tilt your head back slightly. Insert the swab about 2 cm, at least with the entire soft tip of the swab, into the left nostril. Rotate gently